www.endowissen.tv | Beiträge | ECE 2021

Spotlight Discussions

ECE 2021

Endokrine Disruptoren

N. Reisch, H. Hoyer-Kuhn, M. Pavel

ECE 2021

Sequenztherapie der Osteoporose

N. Reisch, H. Hoyer-Kuhn, M. Pavel, H. Siggelkow

ECE 2021

Hypoparathyreodismus neu bewertet

N. Reisch, H. Hoyer-Kuhn, M. Pavel, H. Siggelkow

ECE 2021

Cushing-Syndrom - aktuelle Therapielandschaft

N. Reisch, H. Hoyer-Kuhn, M. Pavel

ECE 2021

Neue Entwicklungen bei AGS-Therapie

N. Reisch, H. Hoyer-Kuhn, M. Pavel, H. Siggelkow

Knochen- und Mineralstoffwechsel

ECE 2021

Challenges of hypoparathyroidism

Prof. Dr. med. Heide Siggelkow

ECE 2021

AAV liver gene therapy-mediated inhibition of FGF23…

Prof. Dr. med. Heide Siggelkow

ECE 2021

Cardiovascular events in adult patients with chronic…

Prof. Dr. med. Heide Siggelkow

ECE 2021

Bone consequences of high dose denosumab to treat an…

Prof. Dr. med. Heide Siggelkow

ECE 2021

One year in bone

Prof. Dr. med. Heide Siggelkow

ECE 2021

The effect of intra-operative autofluorescence…

Prof. Dr. med. Heide Siggelkow

ECE 2021

TransCon PTH as a potential hormone replacement therapy…

Prof. Dr. med. Heide Siggelkow

ECE 2021

Quantifying the real-world clinical and economic burden…

Prof. Dr. med. Heide Siggelkow

ECE 2021

Deficiency or insufficiency of vitamin D and the…

Prof. Dr. med. Heide Siggelkow

ECE 2021

Safety, tolerability and pharmacodynamics of AZP-3601,…

Prof. Dr. med. Heide Siggelkow

ECE 2021

Bisphosphonates after Denosumab withdrawal reduce the…

Prof. Dr. med. Heide Siggelkow

ECE 2021

News about hypophosphatasia

Prof. Dr. med. Heide Siggelkow

ECE 2021

Risk of chronic kidney disease and change in GFR in…

Prof. Dr. med. Heide Siggelkow

ECE 2021

Non-nuclear cataracts in hypoparathyroidism are…

Prof. Dr. med. Heide Siggelkow

Nebenniere

ECE 2021

Adverse events of mitotane treatment in patients with…

Prof. Dr. med. Nicole Reisch

ECE 2021

Results of the ADIUVO trial, the first randomized study…

Prof. Dr. med. Nicole Reisch

ECE 2021

Pre-operative hypercortisolism and post-operative…

Prof. Dr. med. Nicole Reisch

ECE 2021

Steroid metabolomics for the detection of malignancy in…

Prof. Dr. med. Nicole Reisch

ECE 2021

Novel treatment and monitoring options for CAH

Prof. Dr. med. Nicole Reisch

ECE 2021

Salivary steroid and 11‑oxygenated androgen profiles in…

PD Dr. med. Heike Hoyer-Kuhn

ECE 2021

Fascin-1, a novel-circulating marker for the prognosis…

Prof. Dr. med. Nicole Reisch

ECE 2021

Primary results from MATCH: A randomised controlled…

Prof. Dr. med. Nicole Reisch

ECE 2021

Tildacerfont for the treatment of patients with classic…

PD Dr. med. Heike Hoyer-Kuhn

ECE 2021

Neuroendocrine stress response at single cell…

Prof. Dr. med. Nicole Reisch

Hypophyse und Neuroendokrinologie

ECE 2021

Metyrapone treatment in endogenous Cushing’s syndrome.…

Prof. Dr. med. Marianne Pavel

ECE 2021

Thymic neuroendocrine tumor and mortality in MEN 1…

Prof. Dr. med. Marianne Pavel

ECE 2021

Identification of a dose range for once daily oral…

Prof. Dr. med. Marianne Pavel

ECE 2021

Reassessment of the diagnostic criteria of insulinoma:…

Prof. Dr. med. Marianne Pavel

ECE 2021

Can the follow-up imaging interval for non-functioning…

Prof. Dr. med. Marianne Pavel

ECE 2021

Addition of cabergoline to oral octreotide capsules may…

Prof. Dr. med. Marianne Pavel

ECE 2021

Osilodrostat, a potent oral 11β-hydroxylase inhibitor

Prof. Dr. med. Marianne Pavel

ECE 2021

A Phase 3 Large International Noninferiority Trial…

Prof. Dr. med. Marianne Pavel

ECE 2021

Osilodrostat provides sustained control of urinary free…

Prof. Dr. med. Marianne Pavel

ECE 2021

GH replacement in adults

PD Dr. med. Heike Hoyer-Kuhn

Reproduktion und Entwicklung

ECE 2021

Effect of IL-1 receptor antagonism on hyperandrogenemia…

PD Dr. med. Heike Hoyer-Kuhn

ECE 2021

Non-contraceptive therapeutic use of combined oral…

PD Dr. med. Heike Hoyer-Kuhn

ECE 2021

Long-term effects of testosterone replacement therapy

PD Dr. med. Heike Hoyer-Kuhn

Varia

ECE 2021

Endocrine Disruptors - a key challenge for…

PD Dr. med. Heike Hoyer-Kuhn

ECE 2021

Monogenic variants in the Finnish Pediatric Diabetes…

PD Dr. med. Heike Hoyer-Kuhn

ECE 2021

COVID-19 and hormones – the role of Endocrinologists in…

PD Dr. med. Heike Hoyer-Kuhn